South China Research Center for Stem Cell and Regenerative Medicine Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2016
NCT02666391
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now